AlphaMark Advisors, LLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 184 filers reported holding ACORDA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 4.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
AlphaMark Advisors, LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$691,000
-9.9%
36,7480.0%0.36%
-7.8%
Q3 2016$767,000
+30.4%
36,748
+59.4%
0.39%
+11.5%
Q2 2016$588,000
-3.6%
23,0480.0%0.35%
+7.1%
Q1 2016$610,000
-53.1%
23,048
-24.1%
0.32%
-51.0%
Q4 2015$1,300,000
+123.0%
30,384
+38.1%
0.66%
+104.0%
Q3 2015$583,000
-20.5%
22,0000.0%0.32%
-21.4%
Q2 2015$733,00022,0000.41%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders